Loureiro, Jesús <br/><br/>
Tamoxifen ameliorates peritoneal membrane damage by blocking mesothelial to mesenchymal transition in peritoneal dialysis.  [electronic resource] 

 -  PloS one  2013 
 - e61165 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0061165  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Epithelial-Mesenchymal Transition--drug effects<br/>Female<br/>Fibrinolysis--drug effects<br/>Mice<br/>Mice, Inbred C57BL<br/>Neovascularization, Pathologic--drug therapy<br/>Peritoneal Dialysis--adverse effects<br/>Peritoneum--blood supply<br/>Phenotype<br/>Tamoxifen--pharmacology<br/>Transforming Growth Factor beta1--pharmacology